View Clinical Trial (Medical Research Study)
30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-33401(Clinical Trial 221849)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
West Palm Beach |
|
State:
|
|
FL |
| Zip Code: |
|
33401 |
| Conditions: |
|
Dyslipidemias - Coronary Heart Disease - Kidney Disease |
| Purpose: |
|
The objective of this study is to evaluate the safety and effectiveness of the combination
of rosuvastatin and ABT-335 in dyslipidemic subjects with Chronic Kidney Disease (CKD) Stage
3.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Dyslipidemic subjects with Chronic Kidney Disease Stage 3
Exclusion Criteria:
- Patients with certain chronic or unstable medical conditions.
- Patients with unstable dose of medications or receiving Coumadin, cyclosporine, or
certain other medications.
- Pregnant or lactating women, or women intending to become pregnant.
- Patient with diabetes mellitus that is poorly controlled. |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
February 17, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|